Enrique Carrazana Net Worth & Insider Trades
Enrique Carrazana - Chief Medical Officer, Acorda Therapeutics Inc
What is Enrique Carrazana's Net Worth?
The current estimated net worth of Acorda Therapeutics Inc's Chief Medical Officer, Enrique Carrazana, is estimated to be about $4.88M . Enrique Carrazana owns about 32,148 units of Acorda Therapeutics Inc common stock. In the last 3 years at Acorda Therapeutics Inc, Enrique Carrazana has sold an estimated value of $4.85M worth.
What is Enrique Carrazana's Past Insider Trading?
Enrique Carrazana's largest purchase order was 97,993 units , worth over $2.41M on January 12, 2015. Enrique Carrazana's largest sale order was 97,993 units , worth over $4.14M on January 12, 2015. In total, Enrique Carrazana has made about 11 transactions over 3 years of their time at Acorda Therapeutics Inc. Enrique Carrazana usually trades in December, with the busiest year in 2015, 2013 and 2014. The most recent transaction was a sale order of 7,218 units , worth over $274.87K on December 3, 2015.
Enrique Carrazana
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
What is Enrique Carrazana's' Mailing Address?
- Mailing address is 420 Saw Mill River Road Ardsley NY 10502 NY
What are Acorda Therapeutics Inc's Past Insider Trades?
Acorda Therapeutics Inc's most recent insider trade came on March 20, 2023 by Ron Cohen who bought 20,156 units worth $12.59K . In the last 17 years, insiders at Acorda Therapeutics Inc have sold an estimated value of $209.22M and bought an estimated value of $39.66M worth of shares. Insider trading is most common in June, with the busiest year in 2018. The most active traders at the company are David Lawrence, Chief, Ron Cohen, President and CEO, and Jane Wasman, President .
Acorda Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |